financetom
Business
financetom
/
Business
/
Structure's obesity pill shows up to 16.3% weight loss in study
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Structure's obesity pill shows up to 16.3% weight loss in study
Mar 16, 2026 4:19 AM

March 16 (Reuters) - Structure Therapeutics ( GPCR )

said its oral obesity drug aleniglipron delivered up to 16.3%

weight loss, when compared with a placebo after 44 weeks of

treatment in a mid-stage study.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved